tirzepatide fda approval for weight loss approves weight-loss drug Zepbound to treat sleep apnea #Zepbound (#tirzepatide aka #mounjaro) just

GLP-1 retail prices without insurance in 2026 Before we get into savings programs and discount strategies, here is what GLP-1 medications actually cost at full retail

Learn more The same FDA-approved tirzepatide in a multi-dose vial format

Consistency with use is important, and goals should be discussed with your healthcare provider

During shortages of Wegovy, Ozempic, Mounjaro, and Zepbound, the FDA exercised temporary enforcement discretion , allowing compounding pharmacies to help meet patient demand. Once manufacturing stabilized: Semaglutide injection products were removed from the FDA Drug Shortage List Tirzepatide injection products were formally declared resolved Compounding reverted to pre-shortage federal and state limits Broad, shortage-based compounding is no longer allowed in 2026

That is a 6.5 percentage point difference, which on a 220 pound person translates to roughly 14 additional pounds lost